The Valley Desk

NCT03144687 · Interventional trial

A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Participants With Myelofibrosis

Overall registry status Completed

Phase 2

Conditions MPN (Myeloproliferative Neoplasms)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov